VERTEX PHARMACEUTICALS INC / MA Increase (Decrease) in Accounts Payable
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Increase (Decrease) in Accounts Payable of -$31.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$66.70M, a 977.63% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $35.60M, a 35.88% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $38.30M, a 355.95% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$35.30M, a 153.40% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts payable for fiscal 2025 was $36.80M, a 25.66% decline from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts payable for fiscal 2024 was $49.50M, a 1.64% increase from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts payable for fiscal 2023 was $48.70M, a 59.69% decline from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in accounts payable for fiscal 2022 was $120.80M, a 278.68% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$66.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$31.10M 10-Q · filed 2026-08-04 | $7.20M derived: sum of 3 quarters · filed 2026-08-04 | -$28.10M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $35.60M 10-Q · filed 2026-05-05 | $73.90M derived: sum of 2 quarters · filed 2026-05-05 | $38.60M derived: sum of 3 quarters · filed 2026-05-05 | $46.20M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $38.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $3.00M derived: sum of 2 quarters · filed 2026-02-13 | $10.60M derived: sum of 3 quarters · filed 2026-08-04 | $36.80M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | -$35.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$27.70M derived: sum of 2 quarters · filed 2026-08-04 | -$1.50M 10-Q · filed 2025-11-04 | $6.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $33.80M 10-Q · filed 2026-08-04 | $42.20M derived: sum of 3 quarters · filed 2026-08-04 | $108.30M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $26.20M 10-Q · filed 2026-05-05 | $34.60M derived: sum of 2 quarters · filed 2026-05-05 | $100.70M derived: sum of 3 quarters · filed 2026-05-05 | $75.60M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $74.50M derived: sum of 2 quarters · filed 2026-02-13 | $49.40M derived: sum of 3 quarters · filed 2026-02-13 | $49.50M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $66.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $41.00M derived: sum of 2 quarters · filed 2025-11-04 | $41.10M 10-Q · filed 2025-11-04 | $9.30M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | -$25.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$25.00M 10-Q · filed 2025-08-05 | -$56.80M derived: sum of 3 quarters · filed 2026-02-13 | -$47.60M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-06 | -$31.70M derived: sum of 2 quarters · filed 2026-02-13 | -$22.50M derived: sum of 3 quarters · filed 2026-02-13 | $13.10M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | -$31.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$22.60M derived: sum of 2 quarters · filed 2026-02-13 | $13.00M derived: sum of 3 quarters · filed 2026-02-13 | $48.70M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $9.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $44.80M derived: sum of 2 quarters · filed 2024-11-05 | $80.50M 10-Q · filed 2024-11-05 | $240.40M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $35.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $71.30M 10-Q · filed 2024-08-02 | $231.20M derived: sum of 3 quarters · filed 2025-02-13 | $161.30M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $35.70M 10-Q · filed 2024-05-07 | $195.60M derived: sum of 2 quarters · filed 2025-02-13 | $125.70M derived: sum of 3 quarters · filed 2025-02-13 | $171.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $159.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $90.00M derived: sum of 2 quarters · filed 2025-02-13 | $135.30M derived: sum of 3 quarters · filed 2025-02-13 | $120.80M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | -$69.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$24.60M derived: sum of 2 quarters · filed 2023-11-07 | -$39.10M 10-Q · filed 2023-11-07 | $14.80M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $45.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $30.80M 10-Q · filed 2023-08-02 | $84.70M derived: sum of 3 quarters · filed 2024-02-15 | $87.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$14.50M 10-Q · filed 2023-05-02 | $39.40M derived: sum of 2 quarters · filed 2024-02-15 | $41.70M derived: sum of 3 quarters · filed 2024-02-15 | $28.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $53.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $56.20M derived: sum of 2 quarters · filed 2024-02-15 | $42.50M derived: sum of 3 quarters · filed 2024-02-15 | $31.90M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$11.40M derived: sum of 2 quarters · filed 2022-10-28 | -$22.00M 10-Q · filed 2022-10-28 | -$22.04M 10-Q · filed 2021-11-03 | $13.15M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-06-30 | -$13.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$24.30M 10-Q · filed 2022-08-05 | -$24.34M 10-Q · filed 2021-07-30 | $10.85M derived: sum of 3 quarters · filed 2023-02-10 | $12.30M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-03-31 | -$10.60M 10-Q · filed 2022-05-06 | -$10.64M 10-Q · filed 2021-04-30 | $24.55M derived: sum of 2 quarters · filed 2023-02-10 | $26.00M derived: sum of 3 quarters · filed 2023-02-10 | $26.41M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $35.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $36.60M derived: sum of 2 quarters · filed 2023-02-10 | $37.02M derived: sum of 3 quarters · filed 2023-02-10 | $51.30M 10-K · filed 2023-02-10 | $51.28M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $1.87M derived: sum of 2 quarters · filed 2021-11-03 | $16.15M 10-Q · filed 2021-11-03 | $5.56M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $14.70M 10-Q · filed 2021-07-30 | $4.11M derived: sum of 3 quarters · filed 2022-02-09 | $19.97M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $14.29M 10-Q · filed 2021-04-30 | $3.69M derived: sum of 2 quarters · filed 2022-02-09 | $19.56M derived: sum of 3 quarters · filed 2022-02-09 | $15.63M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | -$10.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $5.27M derived: sum of 2 quarters · filed 2022-02-09 | $1.34M derived: sum of 3 quarters · filed 2022-02-09 | -$22.80M 10-K · filed 2022-02-09 | -$22.79M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $15.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $11.94M derived: sum of 2 quarters · filed 2020-10-30 | -$12.21M 10-Q · filed 2020-10-30 | $1.32M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | -$3.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$28.07M 10-Q · filed 2020-07-31 | -$14.54M derived: sum of 3 quarters · filed 2021-02-11 | -$3.75M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | -$24.14M 10-Q · filed 2020-05-01 | -$10.61M derived: sum of 2 quarters · filed 2021-02-11 | $180.00K derived: sum of 3 quarters · filed 2021-02-11 | $10.26M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $13.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $24.32M derived: sum of 2 quarters · filed 2021-02-11 | $34.40M derived: sum of 3 quarters · filed 2021-02-11 | $36.55M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $10.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $20.87M derived: sum of 2 quarters · filed 2019-10-31 | $23.02M 10-Q · filed 2019-10-31 | $24.85M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $10.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $12.23M 10-Q · filed 2019-08-01 | $14.06M derived: sum of 3 quarters · filed 2020-02-13 | $6.93M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $2.15M 10-Q · filed 2019-05-01 | $3.98M derived: sum of 2 quarters · filed 2020-02-13 | -$3.14M derived: sum of 3 quarters · filed 2020-02-13 | $10.19M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$5.29M derived: sum of 2 quarters · filed 2020-02-13 | $8.04M derived: sum of 3 quarters · filed 2020-02-13 | $8.75M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | -$7.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $6.21M derived: sum of 2 quarters · filed 2018-10-25 | $6.92M 10-Q · filed 2018-10-25 | $16.71M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $13.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $14.05M 10-Q · filed 2018-07-26 | $23.83M derived: sum of 3 quarters · filed 2019-02-13 | $26.12M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $717.00K 10-Q · filed 2018-04-27 | $10.50M derived: sum of 2 quarters · filed 2019-02-13 | $12.79M derived: sum of 3 quarters · filed 2019-02-13 | -$10.69M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $12.08M derived: sum of 2 quarters · filed 2019-02-13 | -$11.40M derived: sum of 3 quarters · filed 2019-02-13 | -$11.74M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | -$21.19M derived: sum of 2 quarters · filed 2017-10-30 | -$21.53M 10-Q · filed 2017-10-30 | -$29.52M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | -$23.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$23.82M 10-Q · filed 2017-07-28 | -$31.81M derived: sum of 3 quarters · filed 2018-02-15 | -$22.50M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | -$343.00K 10-Q · filed 2017-04-28 | -$8.34M derived: sum of 2 quarters · filed 2018-02-15 | $981.00K derived: sum of 3 quarters · filed 2018-02-15 | $21.50M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | -$7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $1.32M derived: sum of 2 quarters · filed 2018-02-15 | $21.85M derived: sum of 3 quarters · filed 2018-02-15 | -$1.71M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $9.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $29.84M derived: sum of 2 quarters · filed 2016-10-31 | $6.28M 10-Q · filed 2016-10-31 | $36.88M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $20.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | -$3.03M 10-Q · filed 2016-08-01 | $27.56M derived: sum of 3 quarters · filed 2017-02-23 | $14.34M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | -$23.56M 10-Q · filed 2016-05-03 | $7.04M derived: sum of 2 quarters · filed 2017-02-23 | -$6.18M derived: sum of 3 quarters · filed 2017-02-23 | $514.00K derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $30.59M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $17.38M derived: sum of 2 quarters · filed 2017-02-23 | $24.07M derived: sum of 3 quarters · filed 2017-02-23 | $25.05M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | -$13.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$6.52M derived: sum of 2 quarters · filed 2015-10-30 | -$5.54M 10-Q · filed 2015-10-30 | -$8.77M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | $6.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $7.67M 10-Q · filed 2015-08-04 | $4.44M derived: sum of 3 quarters · filed 2016-02-16 | $11.81M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $978.00K 10-Q · filed 2015-05-04 | -$2.25M derived: sum of 2 quarters · filed 2016-02-16 | $5.12M derived: sum of 3 quarters · filed 2016-02-16 | -$7.68M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | -$3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $4.14M derived: sum of 2 quarters · filed 2016-02-16 | -$8.66M derived: sum of 3 quarters · filed 2016-02-16 | -$49.23M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | $7.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$5.43M derived: sum of 2 quarters · filed 2014-11-06 | -$46.01M 10-Q · filed 2014-11-06 | $46.01M 10-Q · filed 2013-11-07 | -$29.75M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-06-30 | -$12.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$53.37M 10-Q · filed 2014-07-31 | $53.37M 10-Q · filed 2013-08-02 | -$37.12M derived: sum of 3 quarters · filed 2015-02-13 | -$53.80M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | -$40.57M 10-Q · filed 2014-05-05 | -$24.32M derived: sum of 2 quarters · filed 2015-02-13 | -$40.99M derived: sum of 3 quarters · filed 2015-02-13 | -$24.28M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $16.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$421.00K derived: sum of 2 quarters · filed 2015-02-13 | $16.29M derived: sum of 3 quarters · filed 2015-02-13 | $14.89M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | -$16.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $41.00K derived: sum of 2 quarters · filed 2013-11-07 | -$1.36M 10-Q · filed 2013-11-07 | $1.36M 10-Q · filed 2012-11-06 | $24.01M derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-06-30 | $16.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $15.31M 10-Q · filed 2013-08-02 | -$15.31M 10-Q · filed 2012-08-08 | $40.68M derived: sum of 3 quarters · filed 2014-02-11 | $22.63M derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-03-31 | -$1.40M 10-Q · filed 2013-05-08 | $23.96M derived: sum of 2 quarters · filed 2014-02-11 | $5.92M derived: sum of 3 quarters · filed 2014-02-11 | $37.13M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $25.36M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $7.32M derived: sum of 2 quarters · filed 2014-02-11 | $38.53M derived: sum of 3 quarters · filed 2014-02-11 | $37.47M 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | -$18.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $13.17M derived: sum of 2 quarters · filed 2012-11-06 | $12.10M 10-Q · filed 2012-11-06 | $23.24M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $31.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $30.15M 10-Q · filed 2012-08-08 | $41.28M derived: sum of 3 quarters · filed 2013-03-01 | $19.33M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | -$1.07M 10-Q · filed 2012-05-10 | $10.07M derived: sum of 2 quarters · filed 2013-03-01 | -$11.88M derived: sum of 3 quarters · filed 2013-03-01 | $5.72M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $11.13M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$10.82M derived: sum of 2 quarters · filed 2013-03-01 | $6.78M derived: sum of 3 quarters · filed 2013-03-01 | -$1.18M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | -$21.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$4.35M derived: sum of 2 quarters · filed 2011-11-03 | -$12.31M 10-Q · filed 2011-11-03 | $4.73M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $17.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $9.64M 10-Q · filed 2011-08-09 | $26.68M derived: sum of 3 quarters · filed 2012-02-22 | $19.14M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | -$7.96M 10-Q · filed 2011-05-06 | $9.08M derived: sum of 2 quarters · filed 2012-02-22 | $1.54M derived: sum of 3 quarters · filed 2012-02-22 | $6.55M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $17.05M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $9.51M derived: sum of 2 quarters · filed 2012-02-22 | $14.52M derived: sum of 3 quarters · filed 2012-02-22 | -$15.06M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | -$7.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | -$2.53M derived: sum of 2 quarters · filed 2010-10-28 | -$32.10M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | -$24.57M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | -$29.57M 10-Q · filed 2010-05-03 | |||||||
| 2008-12-31 | $19.01M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |